0001802806-20-000003.txt : 20200701 0001802806-20-000003.hdr.sgml : 20200701 20200701160422 ACCESSION NUMBER: 0001802806-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200701 DATE AS OF CHANGE: 20200701 EFFECTIVENESS DATE: 20200701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Compass Therapeutics, Inc. CENTRAL INDEX KEY: 0001738021 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370112 FILM NUMBER: 201005392 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8099 MAIL ADDRESS: STREET 1: 245 FIRST STREET, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Olivia Ventures, Inc. DATE OF NAME CHANGE: 20180419 D 1 primary_doc.xml X0708 D LIVE 0001738021 Compass Therapeutics, Inc. 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-500-8099 DELAWARE Olivia Ventures, Inc. Corporation true 2018 Julie Sunderland c/o Compass Therapeutics, Inc. 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Carl L. Gordon c/o Compass Therapeutics, Inc. 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Thomas J. Schuetz c/o Compass Therapeutics, Inc. 245 First Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Philip Ferneau c/o Compass Therapeutics, Inc. 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Stephen P. Squinto c/o Compass Therapeutics, Inc. 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Vered Bisker-Leib c/o Compass Therapeutics, Inc. 245 First Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Other Decline to Disclose 06b false 2020-06-17 false true true Merger with Olivia Ventures, Inc. 0 195276780 195276780 0 false 114 0 0 0 false Compass Therapeutics, Inc. /s/ Thomas Schuetz Thomas Schuetz Chief Executive Officer 2020-07-01